BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12558785)

  • 1. Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats.
    Van Damme A; Chuah MK; Dell'accio F; De Bari C; Luyten F; Collen D; VandenDriessche T
    Haemophilia; 2003 Jan; 9(1):94-103. PubMed ID: 12558785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice.
    Chuah MK; Van Damme A; Zwinnen H; Goovaerts I; Vanslembrouck V; Collen D; VandenDriessche T
    Hum Gene Ther; 2000 Mar; 11(5):729-38. PubMed ID: 10757352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow stromal cells as targets for gene therapy of hemophilia A.
    Chuah MK; Brems H; Vanslembrouck V; Collen D; VandenDriessche T
    Hum Gene Ther; 1998 Feb; 9(3):353-65. PubMed ID: 9508053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
    Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
    Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic levels of human factor VIII in mice implanted with encapsulated cells: potential for gene therapy of haemophilia A.
    García-Martín C; Chuah MK; Van Damme A; Robinson KE; Vanzieleghem B; Saint-Remy JM; Gallardo D; Ofosu FA; Vandendriessche T; Hortelano G
    J Gene Med; 2002; 4(2):215-23. PubMed ID: 11933222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
    Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
    J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells.
    Van Damme A; Thorrez L; Ma L; Vandenburgh H; Eyckmans J; Dell'Accio F; De Bari C; Luyten F; Lillicrap D; Collen D; VandenDriessche T; Chuah MK
    Stem Cells; 2006 Apr; 24(4):896-907. PubMed ID: 16339997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A.
    Chuah MK; VandenDriessche T; Morgan RA
    Hum Gene Ther; 1995 Nov; 6(11):1363-77. PubMed ID: 8573610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustaining expression of B domain-deleted human factor VIII mediated by using lentiviral vectors in NOD/SCID mouse.
    Li YJ; Chen C; Zeng LY; Cao J; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):658-63. PubMed ID: 22739177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice.
    Kaneko S; Onodera M; Fujiki Y; Nagasawa T; Nakauchi H
    Hum Gene Ther; 2001 Jan; 12(1):35-44. PubMed ID: 11177540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors.
    Matsui H; Shibata M; Brown B; Labelle A; Hegadorn C; Andrews C; Hebbel RP; Galipeau J; Hough C; Lillicrap D
    Stem Cells; 2007 Oct; 25(10):2660-9. PubMed ID: 17615271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient production of human FVIII in hemophilic mice using lentiviral vectors.
    Kootstra NA; Matsumura R; Verma IM
    Mol Ther; 2003 May; 7(5 Pt 1):623-31. PubMed ID: 12718905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level expression of porcine factor VIII from genetically modified bone marrow-derived stem cells.
    Gangadharan B; Parker ET; Ide LM; Spencer HT; Doering CB
    Blood; 2006 May; 107(10):3859-64. PubMed ID: 16449528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained phenotypic correction of hemophilia a mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells.
    Moayeri M; Ramezani A; Morgan RA; Hawley TS; Hawley RG
    Mol Ther; 2004 Nov; 10(5):892-902. PubMed ID: 15509507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice.
    Schiedlmeier B; Kühlcke K; Eckert HG; Baum C; Zeller WJ; Fruehauf S
    Blood; 2000 Feb; 95(4):1237-48. PubMed ID: 10666196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow stromal cell-mediated gene therapy for hemophilia A: in vitro expression of human factor VIII with high biological activity requires the inclusion of the proteolytic site at amino acid 1648.
    Chiang GG; Rubin HL; Cherington V; Wang T; Sobolewski J; McGrath CA; Gaffney A; Emami S; Sarver N; Levine PH; Greenberger JS; Hurwitz DR
    Hum Gene Ther; 1999 Jan; 10(1):61-76. PubMed ID: 10022531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice.
    Ramezani A; Zweier-Renn LA; Hawley RG
    Thromb Haemost; 2011 Apr; 105(4):676-87. PubMed ID: 21264447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes.
    Andrews JL; Weaver L; Kaleko M; Connelly S
    Haemophilia; 1999 May; 5(3):160-8. PubMed ID: 10444282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A.
    Shi Q; Wilcox DA; Fahs SA; Fang J; Johnson BD; DU LM; Desai D; Montgomery RR
    J Thromb Haemost; 2007 Feb; 5(2):352-61. PubMed ID: 17269937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human factor VIII expression in retrovirus vector-transduced bone marrow stromal cells].
    Guo X; Wang H; Chu H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):461-3. PubMed ID: 11758224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.